Search
for

    Glossary Primary Closure

    method of directly closing wound edges for optimal healing

    Primary closure refers to the method of closing a wound by bringing the edges together directly, usually with sutures, staples, or adhesive. This technique is often used in surgical procedures, including hair transplant surgeries, to promote faster healing and minimize scarring. For professionals, it is crucial to ensure that the wound edges are well-aligned to optimize the healing process and aesthetic outcome.

    Related Terms

    Research

    5 / 1000+ results

      research The Surgical Management of Extensive Cases of Acne Keloidalis Nuchae

      72 citations , November 2000 in “Archives of Dermatology”
      This study found that excision with primary closure is an effective surgical treatment for extensive acne keloidalis nuchae, with good cosmetic results and minimal recurrence observed among patients.
      Scalp Reconstruction Techniques After Oncologic Resection

      research Scalp reconstruction

      66 citations , October 2006 in “Journal of Surgical Oncology”
      This review discusses current techniques for scalp reconstruction following oncologic surgery and reports no new clinical outcomes, emphasizing the importance of tailored approaches for satisfactory closure.

      research Surgical Management of Scalp Infantile Hemangiomas

      15 citations , June 2015 in “Journal of Craniofacial Surgery”
      This study suggests that surgical intervention for scalp infantile hemangiomas, often necessary due to complications like alopecia and ulceration, generally leads to good aesthetic outcomes and satisfactory hair growth.
      Revision Surgical Hair Restoration: Repair of Undesirable Results

      research Revision Surgical Hair Restoration: Repair of Undesirable Results

      5 citations , July 1999 in “Plastic and Reconstructive Surgery”
      This study found that reparative surgical techniques significantly improved the appearance of patients dissatisfied with previous hair restoration procedures, with minor and correctable complications.

    Community Join

    2 / 1000+ results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

       133 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.